Technical Analysis for MIRM - Mirum Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -2.95% | |
200 DMA Resistance | Bearish | -2.95% | |
Fell Below 50 DMA | Bearish | -2.95% | |
Volume Surge | Other | -2.95% | |
BB Squeeze Ended | Range Expansion | -2.95% | |
Below Lower BB | Weakness | -2.95% | |
Lower Bollinger Band Touch | Weakness | -2.95% |
Alert | Time |
---|---|
Down 3% | about 20 hours ago |
Rose Above Lower Bollinger Band | about 21 hours ago |
Fell Below Previous Day's Low | about 21 hours ago |
Down 2 % | about 21 hours ago |
Down 1% | about 21 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Mirum Pharmaceuticals, Inc., a clinical-stage therapeutics company, develops and produces therapies for patients with cholestatic liver diseases with a focus on rare pediatric conditions. The company's lead product candidate is maralixibat, a Phase 3-ready investigational oral drug with indications, including Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). It is also developing Volixibat, an investigational oral inhibitor of ASBT, a protein that is primarily responsible for recycling bile acids from the intestine to the liver. The company was incorporated in 2018 and is based in Foster City, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Acid Recycling Hepatology Liver Disease Progressive Digestive Diseases Liver Bile Acid Primary Biliary Cholangitis Cholestasis Intrahepatic Cholestasis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Acid Recycling Hepatology Liver Disease Progressive Digestive Diseases Liver Bile Acid Primary Biliary Cholangitis Cholestasis Intrahepatic Cholestasis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 35.56 |
52 Week Low | 21.835 |
Average Volume | 603,036 |
200-Day Moving Average | 28.39 |
50-Day Moving Average | 27.61 |
20-Day Moving Average | 28.18 |
10-Day Moving Average | 27.59 |
Average True Range | 1.32 |
RSI (14) | 37.89 |
ADX | 19.65 |
+DI | 18.42 |
-DI | 27.51 |
Chandelier Exit (Long, 3 ATRs) | 26.26 |
Chandelier Exit (Short, 3 ATRs) | 29.61 |
Upper Bollinger Bands | 29.92 |
Lower Bollinger Band | 26.44 |
Percent B (%b) | -0.13 |
BandWidth | 12.35 |
MACD Line | -0.31 |
MACD Signal Line | -0.07 |
MACD Histogram | -0.2465 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 27.94 | ||||
Resistance 3 (R3) | 28.04 | 27.49 | 27.61 | ||
Resistance 2 (R2) | 27.49 | 26.99 | 27.44 | 27.50 | |
Resistance 1 (R1) | 26.74 | 26.68 | 26.46 | 26.63 | 27.39 |
Pivot Point | 26.19 | 26.19 | 26.05 | 26.13 | 26.19 |
Support 1 (S1) | 25.43 | 25.69 | 25.16 | 25.33 | 24.57 |
Support 2 (S2) | 24.88 | 25.38 | 24.83 | 24.46 | |
Support 3 (S3) | 24.13 | 24.88 | 24.35 | ||
Support 4 (S4) | 24.02 |